跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AAT therapy
首页
药物
AAT therapy
AAT therapy
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Nucleic acids encoding novel proteins in enteroaggregative Escherichia coli (EAEC)
US 7141662 B2
申请人: UNIV MARYLAND
优先权: 2002
US
20 件公开
NOVEL THERAPEUTIC POLYPEPTIDE
EP 4705336 A1
申请人: KING PAUL THOMAS
优先权: 2023
CN
EP
US
WO
5 件公开
OXIDATION-RESISTANT AAT GENE THERAPY
EP 3600345 B1
申请人: UNIV CORNELL
优先权: 2017
EP
US
WO
4 件公开
METHODS OF TREATING IMMUNE DYSFUNCTION IN LIVER CANCER WITH TOLL-LIKE RECEPTOR AGONISTS
US 20250101438 A1
申请人: TRISALUS LIFE SCIENCES INC
优先权: 2022
CN
US
2 件公开
ALVELESTAT AND ALPHA- 1 ANTITRYPSIN FOR TREATING RESPIRATORY DISORDERS
EP 4791400 A1
申请人: MEREO BIOPHARMA 4 LTD
优先权: 2023
EP
WO
2 件公开
COMPOSITIONS, METHODS AND USES FOR ALPHA-1 ANTITRYPSIN FUSION MOLECULES
US 2014348859 A1
申请人: KIM SOOHYUN
优先权: 2013
US
2 件公开
Use of alpha 1-antichymotrypsin in combination with alpha-1-antitrypsin for treating/preventing diabetes associated or poorly healing arterial wounds
EP 1415664 A1
申请人: SWITCH BIOTECH AG
优先权: 2002
EP
Novel proteins in Enteroaggregative Escherichia Coli (EAEC) useful for diagnosis and therapy of EAEC infections
EP 1917975 A1
申请人: UNIV MARYLAND
优先权: 2002
EP
Method for ameliorating radiation exposure effects with alpha-1 antitrypsin
US 8980574 B2
申请人: CRAPO JAMES D
优先权: 2012
US
TFEB GENE THERAPY OF ALPHA-1-ANTITRYPSIN DEFICIENCY
US 2015079051 A1
申请人: FOND TELETHON
优先权: 2012
US
第 1 / 2 页
上一页
下一页
药物
反馈